$4,656.79 travel Payment -- Teva Pharmaceuticals to Dr. Mark Perez
Teva Pharmaceuticals covers significant travel and lodging costs for Pain Management specialist Dr. Mark Perez related to Dupixent.
This page provides a detailed analysis of a $4,656.79 travel payment from Teva Pharmaceuticals to Dr. Mark Perez. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $4,656.79 |
| Payment Type | travel |
| Payment Nature | Travel and Lodging |
| Pharmaceutical Company | Teva Pharmaceuticals |
| Physician | Dr. Mark Perez |
| NPI Number | 1355130498 |
| Physician Specialty | Pain Management |
| Location | City, AL |
| Date of Payment | 2024-10-26 |
| Related Drug/Device | Dupixent |
| Conflict Assessment | Moderate -- Worth Noting |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Teva Pharmaceuticals made a $4.7K travel payment to Mark Perez, a Pain Management specialist in City, AL. The payment was associated with Dupixent. The payment of $4,656.79 to Dr. Mark Perez from Teva Pharmaceuticals for travel and lodging related to Dupixent is a significant amount for a single payment. The payment covers travel and lodging, suggesting an educational event or conference attendance. The specific drug mentioned, Dupixent, is a biologic used for various inflammatory conditions, including asthma and eczema.
Patient Guidance: What This Payment Means for You
If you are a patient, this payment indicates that your doctor may have received support for travel and lodging expenses related to medical education or events concerning medications like Dupixent. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
For a Pain Management specialist, a payment of this size for travel and lodging is moderate, depending on the nature and duration of the educational event or conference.
Regulatory Context: Sunshine Act Requirements
This payment falls under the Sunshine Act's reporting requirements for transfers of payment from manufacturers to physicians, requiring disclosure of the amount, nature, and associated parties.
Related Topics
This payment is related to the following healthcare transparency topics:
- pharmaceutical-payments
- physician-payments
- travel-and-lodging
- drug-education
- pain-management
- dupixent
- teva-pharmaceuticals
Understanding travel Payments
Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.
Frequently Asked Questions About This Payment
What was this $4.7K payment for?
This was a travel payment of $4.7K from Teva Pharmaceuticals to Mark Perez, categorized as "Travel and Lodging". It was associated with Dupixent. The payment was reported under the Sunshine Act (CMS Open Payments).
Does Mark Perez accept pharmaceutical money?
Yes, Mark Perez received this $4.7K payment from Teva Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Mark Perez's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this travel payment?
A travel payment of $4.7K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Pain Management?
To compare this payment against Pain Management averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Pain Management physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Mark Perez's relationship with Teva Pharmaceuticals?
The payment amount is substantial for travel and lodging, warranting a closer look at the associated activities. This $4.7K travel payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Pain Management?
The payment is linked to a specific drug, Dupixent, indicating a focus on its promotion or education.
What should patients do after learning about this payment?
If you are a patient, this payment indicates that your doctor may have received support for travel and lodging expenses related to medical education or events concerning medications like Dupixent.
What else should I know about this travel payment?
Dr. Perez's specialty in Pain Management may align with conditions treated by Dupixent, though it's primarily used for other indications.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.